Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
Takeda K, Kawasaki Y, Sakayauchi T, Takahashi C, Katagiri Y, Tanabe T, Ishikawa Y, Fujimoto K, Kubozono M, Kozumi M, Abe K, Narazaki K, Tasaka S, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Ito A, Jingu K. Takeda K, et al. Among authors: katagiri y. Asia Ocean J Nucl Med Biol. 2023;11(1):13-22. doi: 10.22038/AOJNMB.2022.67136.1468. Asia Ocean J Nucl Med Biol. 2023. PMID: 36619192 Free PMC article.
Definitive Chemoradiotherapy for Advanced Pulmonary Sarcomatoid Carcinoma.
Takeda K, Matsushita H, Kubozono M, Tanabe T, Ishikawa Y, Yamamoto T, Kozumi M, Takahashi N, Katagiri Y, Tasaka S, Fukui K, Takeda K, Fujishima F, Ichinose M, Jingu K. Takeda K, et al. Among authors: katagiri y. Intern Med. 2016;55(22):3325-3330. doi: 10.2169/internalmedicine.55.6990. Epub 2016 Nov 15. Intern Med. 2016. PMID: 27853077 Free PMC article.
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice.
Yamamoto T, Tsukita Y, Katagiri Y, Matsushita H, Umezawa R, Ishikawa Y, Takahashi N, Suzuki Y, Takeda K, Miyauchi E, Saito R, Katsuta Y, Kadoya N, Jingu K. Yamamoto T, et al. Among authors: katagiri y. BMC Cancer. 2022 Apr 4;22(1):364. doi: 10.1186/s12885-022-09354-1. BMC Cancer. 2022. PMID: 35379201 Free PMC article.
Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study.
Yamamoto T, Katagiri Y, Tsukita Y, Matsushita H, Umezawa R, Katsuta Y, Kadoya N, Takahashi N, Suzuki Y, Takeda K, Kishida K, Omata S, Miyauchi E, Saito R, Jingu K. Yamamoto T, et al. Among authors: katagiri y. Cancers (Basel). 2022 Aug 18;14(16):3993. doi: 10.3390/cancers14163993. Cancers (Basel). 2022. PMID: 36010985 Free PMC article.
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.
Takahashi N, Yamamoto T, Matsushita H, Sugawara T, Kubozono M, Umezawa R, Ishikawa Y, Kozumi M, Katagiri Y, Tasaka S, Takeda K, Takeda K, Dobashi S, Jingu K. Takahashi N, et al. Among authors: katagiri y. J Radiat Res. 2016 Nov;57(6):655-661. doi: 10.1093/jrr/rrw048. Epub 2016 Jul 15. J Radiat Res. 2016. PMID: 27422935 Free PMC article.
Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
Yamamoto T, Kadoya N, Sato Y, Matsushita H, Umezawa R, Kubozono M, Ishikawa Y, Kozumi M, Takahashi N, Morishita Y, Katagiri Y, Sato K, Ito K, Takeda K, Jingu K. Yamamoto T, et al. Among authors: katagiri y. Clin Lung Cancer. 2018 Jan;19(1):e85-e90. doi: 10.1016/j.cllc.2017.05.022. Epub 2017 Jun 8. Clin Lung Cancer. 2018. PMID: 28655592
442 results